IL1B and lymphoma: Vanga et al. [27], synthesized sixteen novel (+)-UA-based triazole hybrids and evaluated their in vitro anti-inflammatory potential against TNF-α and IL-1β release in the LPS-stimulated human lymphoma U937 cell line.